Germano Geno J 4

What Happened Germano Geno J, a director of Entera Bio Ltd. (ENTX), made an open-market purchase of 20,000 shares on March 9, 2026 at $1.30 per share, for a total cost of $26,000. This was a direct purchase (transaction code P), which insiders buying stock can be interpreted as a positive signal, though the filing does not state the insider’s motives.

Key Details

• Transaction date: March 9, 2026. Price: $1.30 per share. Total value: $26,000.
• Filing date: March 11, 2026 — filed within the standard Section 16 reporting window (timely).
• Transaction type/code: Open-market purchase (P = Purchase).
• Shares owned after transaction: Not specified in the provided filing details.
• Footnotes/plan: No 10b5-1 plan, tax-withholding, or other special notes provided in the supplied data.

Context

• Small-dollar open-market purchases like this show an insider put some personal capital to work, but $26k is modest relative to typical institutional levels.
• For retail investors, insider purchases are one data point among many; they do not guarantee future performance and motives are not disclosed.